Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
作者信息
Cooper B, Bunn H F, Propper R D, Nathan D G, Rosenthal D S, Moloney W C
出版信息
Trans Assoc Am Physicians. 1977;90:335-41.
PMID:611665
Abstract
摘要
相似文献
1
Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.成人输血性血色素沉着症患者持续给予去铁胺的评估。
Trans Assoc Am Physicians. 1977;90:335-41.
2
Iron chelating therapy in thalassemia: current problems.地中海贫血的铁螯合疗法：当前问题
Haematologica. 1990 Sep-Oct;75 Suppl 5:84-8.
3
Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.
Lancet. 1977 May 7;1(8019):977-9. doi: 10.1016/s0140-6736(77)92279-6.
4
5
Vitamin C and iron.
N Engl J Med. 1981 Jan 15;304(3):170-1. doi: 10.1056/NEJM198101153040311.
6
7
[Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].[去铁胺治疗含铁血黄素沉着症。持续皮下输注期间的粪便铁排泄]
Dtsch Med Wochenschr. 1984 Nov 2;109(44):1682-5. doi: 10.1055/s-2008-1069435.
8
[Therapy of hemosiderosis with deferoxamine].[用去铁胺治疗含铁血黄素沉着症]
Dtsch Med Wochenschr. 1984 Nov 2;109(44):1669-70. doi: 10.1055/s-2008-1069432.
9
Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.输血性含铁血黄素沉着症。用去铁胺B治疗的一例报告。
J Iowa Med Soc. 1965 Jun;55(6):312-6.
10
Iron metabolism and iron chelation in the thalassaemia disorders.
Haematologica. 1990 Sep-Oct;75 Suppl 5:66-71.
Zotero 插件